FDA Inspection
AxoGen CorporationAxoGen Corporation – FDA Inspection, Mar 13, 2015
Record Details
This FDA Inspection record concerns AxoGen Corporation, with an inspection on March 13, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AxoGen Corporation
- Inspection Date
- March 13, 2015
- Product Type
- Biologics
View Company Profile
ID · 5df42445-5b59-4ca8-8417-4e29551a6bc5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 919999
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of AxoGen Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2026 | Not classified | Cincinnati District Office | |
| September 22, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 28, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 14, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for AxoGen Corporation
- FDA Inspection 1315568 - 2026-04-09
- FDA Inspection 1180500 - 2022-09-22
- FDA Inspection 990232 - 2016-10-28
- FDA Inspection 823344 - 2013-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.